Growth Metrics

Emergent BioSolutions (EBS) Amortization - Goodwill (2022 - 2023)

Historic Amortization - Goodwill for Emergent BioSolutions (EBS) over the last 2 years, with Q3 2023 value amounting to $218.2 million.

  • Emergent BioSolutions' Amortization - Goodwill changed N/A to $218.2 million in Q3 2023 from the same period last year, while for Dec 2024 it was $218.2 million, marking a year-over-year decrease of 297.91%. This contributed to the annual value of $218.2 million for FY2023, which is 315671.64% up from last year.
  • Emergent BioSolutions' Amortization - Goodwill amounted to $218.2 million in Q3 2023.
  • Over the past 5 years, Emergent BioSolutions' Amortization - Goodwill peaked at $218.2 million during Q3 2023, and registered a low of $6.7 million during Q4 2022.